All Episodes

Effectiveness and safety of empagliflozin in routine care patients: results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study

Real-World CGM Comparison of Teneligliptin+Dapagliflozin, Sitagliptin+Dapagliflozin, and Linagliptin+Empagliflozin in Indian T2DM: Amplify-TIR Study

Fasting and postprandial kidney haemodynamic effects of empagliflozin and linagliptin in mono- and combination therapy compared to gliclazide in overweight people with type 2 diabetes

Self-care practices in diabetes among populations in India: a systematic review and meta-analysis

Comparison of Empagliflozin-Linagliptin with Empagliflozin- Metformin Combination Therapy in Assessing Cardiovascular Profile and Anemia in Type 2 Diabetic Patients

Clinical Outcomes with the Use of Dipeptidyl Peptidase-4(DPP-4) Inhibitor Among Patients with Diabetes Mellitus and COVID-19: A Systematic Review of Observational Studies

The Effectiveness of SGLT-2 Inhibitors vs GLP-1 Receptor Agonists in Enhancing Kidney Function and Glycemic Control for Diabetes Mellitus Patients with CKD: A Narrative Review

The rising burden of diabetes and state-wise variations in India: insights from the Global Burden of Disease Study 1990–2021 and projections to 2031

Dipeptidyl Peptidase 4 Inhibitors: Novel Therapeutic Agents in the Management of Type II Diabetes Mellitus

Early combination therapy for the treatment of type 2 diabetes mellitus: systematic review and meta-analysis

Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes

Clinical Efficacy and Safety of SGLT2 Inhibitors and DPP-4 Inhibitors Combination in Asian Patients with Type 2 Diabetes Inadequately Treated with Metformin

Welcome to AjaDuo Update Podcast